This POSTbrief provides a brief overview of assisted dying, including ethical debate and stakeholder opinion. It examines how assisted dying functions within health services in countries where it is a legal option, focusing on jurisdictions where most data are available on outcomes: Belgium, Canada, the Netherlands, Oregon (United States), Switzerland and Victoria (Australia). It also covers evidence and expert opinion on key practical considerations that are raised in the context of assisted dying.
Documents to download
Autism (506 KB , PDF)
Autistic people process their environment differently to non-autistic people, resulting in relative strengths or difficulties, which can vary across contexts and throughout the lifespan. Autism affects everyone differently and is commonly referred to as a spectrum or constellation. It is thought that at least 1% of the world’s population, or 700,000 people in the UK, are autistic. It is recommended that a diagnostic referral be made within three months of reporting concerns to a healthcare professional, but only 18% of local authorities in England reported meeting this target in 2018.
Many autistic people have co-occurring conditions. The most common are mental health problems, other conditions which affect the developing brain (e.g. learning disability, and attention-deficit hyperactivity disorder), and health conditions such as sleep problems. Autistic people have a lower life expectancy than non-autistic people and are believed to be at a higher risk of suicide. Interventions for autistic people should aim to improve quality of life and provide an individual with the skills they need to reach their full potential. Interventions for co-occurring conditions, such as anxiety, often work best when they are personalised and adapted for an autistic person.
Each of the devolved nations in the UK has an Autism Strategy or other autism-relevant policies, which provide statutory guidance for service provision. In England, reports show that there has been little improvement since 2016 on service provision for autistic adults – the two greatest falls in service ratings have been reported in Employment and Service Planning. Autistic people continue to experience poor health outcomes, and are over-represented in figures on unemployment, school exclusions, institutionalised care and the criminal justice system. Research has suggested that improvement of quality of life, and reduction of service costs, could be produced by providing effective and timely support for autistic people and their families.
- Autism affects at least 1% of the population, although prevalence is likely to be under-estimated. Autism is thought to be under-recognised in adults, women and girls, non-binary people, and those from the ethnic minorities.
- Autism frequently co-occurs with other conditions, including mental health conditions, and other neurodevelopmental conditions which affect the developing brain, such as attention-deficit hyperactivity disorder and learning disability. It is estimated that up to 70% of autistic people have at least one mental health condition.
- A range of interventions are available for autistic people. These include treatment of co-occurring conditions (e.g. epilepsy) and providing support for parents and families. There are many autism interventions available to individuals and their families, such as pharmaceutical or behavioural approaches, which do not have a robust scientific evidence base, and can cause significant harm.
- The Autism Act (2009) and relevant autism strategies have increased autism awareness among professionals and the general public. However, autistic people continue to be disadvantaged in areas such as school exclusions, unemployment figures, and in the criminal justice system.
POSTnotes are based on literature reviews, interviews, and consultations with a range of stakeholders, and are externally peer reviewed. POST would like to thank interviewees and peer reviewers* for kindly giving up their time during the preparation:
All-Party Parliamentary Group on Autism*
Ambitious About Autism*
Autism Community Research Network @ Southampton (ACoRNS)
Autism Task and Finish Group, British Psychological Society*
Department for Education*
Department of Health and Social Care*
National Autistic Society*
Play in Education, Development and Learning (PEDAL), University of Cambridge
Dr. Carrie Allison, Autism Research Centre (ARC), University of Cambridge*
Professor Simon Baron-Cohen, Autism Research Centre (ARC), University of Cambridge*
Dr. Sam Brice, Newcastle University
Professor Bryony Beresford, University of York
Professor Mark Brosnan, Centre for Applied Autism Research (CAAR), University of Bath*
Dr. Carol Buckley, Royal College of General Practitioners*
Dr. Sarah Cassidy, University of Nottingham
Professor Tony Charman, King’s College London*
Dr. Laura Crane, Centre for Research in Autism and Education (CRAE), University College London*
Lee Corless, JP Morgan and Chase
Dr. Max Davie, Royal College of Paediatrics and Child Health
Dr. Sue Fletcher-Watson, University of Edinburgh*
Emeritus Professor Dame Uta Frith, University College London
Deborah Garland, National Autistic Society
Amanda Gibbs, Autism expert and trainer*
Rt. Hon. Dame Cheryl Gillan MP, All Party Parliamentary Group on Autism*
Professor Gyles Glover, Public Health England*
Professor Jonathan Green, University of Manchester
Anne-Marie Gregory, Autism activist
Professor Francesca Happé, King’s College London*
Dr. Phil Heslop, Northumbria University
Dr. Laura Hull, University College London
Dr. Barry Ingham, Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
Carly Jones MBE, British Autism Advocate, Honours and MoJ Public Appointee*
Professor Emily Jones, Birkbeck University of London
Professor Martin Knapp, London School of Economics*
Kate Linden, Newcastle University
Dr. Katie Maras, Centre for Applied Autism Research (CAAR), University of Bath
Mahlia Amatina, Neurodivergent Visual Artist
Emerita Professor Helen McConachie, Newcastle University
Panda Mery, Productive Irritant
Dr. Damian Milton, Tizard Centre at University of Kent*
Dr. Nell Munro, University of Nottingham
Dr. Dinah Murray, Productive Irritant*
Lorraine O’Shea, UK Parliament*
Professor Jeremy Parr, Newcastle University
Stephen Patterson, Autism in Mind
Professor Jacqui Rodgers, Newcastle University*
Carole Rutherford, Autism in Mind
Dr. Felicity Sedgewick, University of Bristol
Professor Emily Simonoff, King’s College London
Dr. Eleanor Smith, Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
Letesia Smith, Autism in Mind
Colin Wilson, Newcastle University
*Denotes those who acted as external reviewers of the briefing.
This briefing was updated on 19 July 2022 to clarify the language around undiagnosis of autism.
Documents to download
Autism (506 KB , PDF)
Energy security concerns have risen over the last year. This has been brought about by high international gas and electricity prices, and the possibility of gas shortages during winter 2022, driven largely as a consequence of Russia’s war in Ukraine. This POSTnote examines the risks to the UK’s energy security, current practices for ensuring energy security, and measures that might be taken to enhance energy security as the UK transitions towards a net zero economy.
Palliative and end of life care are increasingly in demand as people are living longer and with multiple long-term conditions. However, an estimated 100,000 people in the UK that could benefit from palliative care die without receiving it each year. There is substantial evidence that inequalities in access to palliative and end of life care relate to various sociodemographic factors. Experts have highlighted that access to palliative and end of life care may improve quality of life for patient and family and reduce symptom burden. This POSTnote summarises the key components of palliative and end of life care and recent changes in UK policy. It identifies inequalities and challenges to accessible provision. It also reviews evidence on the impact of the COVID-19 pandemic on the provision of care and outlines key trends.